Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2015			2014			2013
Net sales
Interventional Cardiology	$	2,242		$	2,092		$	1,995
Peripheral Interventions	975			861			805
Cardiovascular	3,217			2,953			2,800
Cardiac Rhythm Management	1,934			1,922			1,882
Electrophysiology	248			228			154
Rhythm Management	2,182			2,150			2,036
Endoscopy	1,422			1,343			1,277
Urology and Pelvic Health	735			542			505
Neuromodulation	512			474			454
MedSurg	2,669			2,359			2,236
Net sales allocated to reportable segments	8,068			7,462			7,072
Sales generated from business divestitures	—			4			58
Impact of foreign currency fluctuations	(591		)	(86		)	13
	$	7,477		$	7,380		$	7,143

Reconciliation of depreciation by reportable segment to total [Table Text Block]

	Year Ended December 31,
(in millions)	2015			2014		2013
Depreciation expense
Cardiovascular	$	116		$	120	$	111
Rhythm Management	94			92		99
MedSurg	73			75		73
Depreciation expense allocated to reportable segments	283			287		283
Impact of foreign currency fluctuations	(9		)	—		(4		)
	$	274		$	287	$	279

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2015			2014			2013
Income (loss) before income taxes
Cardiovascular	$	972		$	767		$	665
Rhythm Management	328			289			211
MedSurg	856			746			679
Operating income allocated to reportable segments	2,156			1,802			1,555
Corporate expenses and currency exchange	(486		)	(308		)	(203		)
Goodwill and intangible asset impairment charges; pension termination charges; and acquisition-, divestiture-, litigation-, and restructuring-related net charges	(1,502		)	(1,357		)	(822		)
Amortization expense	(495		)	(438		)	(410		)
Operating income (loss)	(327		)	(301		)	120
Other expense, net	(323		)	(208		)	(343		)
	$	(650	)	$	(509	)	$	(223	)

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	As of December 31,
(in millions)	2015		2014
Total assets			(restated*)
Cardiovascular	$	1,583	$	1,501
Rhythm Management	1,279		1,329
MedSurg	1,141		982
Total assets allocated to reportable segments	4,003		3,812
Goodwill	6,473		5,898
Other intangible assets, net	6,194		5,606
All other corporate assets	1,463		1,708
	$	18,133	$	17,024

Reconciliation of sales by division and region to consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2015		2014		2013
Net sales
Interventional Cardiology	$	2,033	$	2,057	$	1,997
Cardiac Rhythm Management	1,807		1,912		1,886
Endoscopy	1,306		1,323		1,280
Peripheral Interventions	904		850		809
Urology and Pelvic Health	693		535		505
Neuromodulation	501		472		453
Electrophysiology	233		227		155
	7,477		7,376		7,085
Sales generated from divested businesses	—		4		58
	$	7,477	$	7,380	$	7,143
United States	$	4,229	$	3,885	$	3,743
Japan	602		678		744
Other countries	2,646		2,813		2,598
	7,477		7,376		7,085
Sales generated from divested businesses	—		4		58
	$	7,477	$	7,380	$	7,143

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]

	As of December 31,
(in millions)	2015		2014		2013
Long-lived assets
United States	$	1,018	$	1,002	$	998
Ireland	170		197		240
Other foreign countries	302		308		308
Property, plant and equipment, net	1,490		1,507		1,546
Goodwill	6,473		5,898		5,693
Other intangible assets, net	6,194		5,606		5,950
	$	14,157	$	13,011	$	13,189